We finally have the technology, infrastructure, and the political will to end the US HIV epidemic, write the Brown University ...

One in 10 clinics in SA will start to hand out a twice-a-year anti-HIV jab as early as February. The country’s medicines ...

By Dickens Okinyi Kenya’s ongoing fight against HIV has entered a new phase with the roll out of Lenacapavir, a groundbreaking long-acting HIV prevention and treatment drug, set to take place in 2026.

The antibody, called 04_A06, blocked 98.5% of more than 300 different HIV strains in lab tests, including many resistant to ...

O AHF Global Public Health Institute para a América Latina e Caribe, em parceria com o Instituto Nacional de Saúde Pública do ...

Source: ‘Miracle’ HIV shot rollout in Zimbabwe sparks debate – DW – 10/16/2025 Zimbabwe is among 10 nations rolling out ...

In response, the South African National Treasury allocated R750 million in emergency funding to prevent service interruptions ...

Zimbabwe is among 10 nations rolling out lenacapavir, a twice-yearly HIV prevention shot. Experts call it a breakthrough, but ...

The biopharma will aim to bolster its pipeline, with plans to present updated results for novel long-acting combination ...

ViiV found by GSK (GSK) and Pfizer (PFE) are in focus as its long acting HIV PrEP therapy cabotegravir outperforms Gilead's lenacapavir in Phase 1 trial. Read more here.

More than 40 years after the first AIDS cases, new long-acting drugs and antibody-based therapies are reviving hopes that HIV ...

The Institute of Human Virology Nigeria (IHVN) has assured people living with HIV not to fear accessing their free care and ...